Robert Dillard
Robert Dillard is a contributing writer with Cancer Nursing Today and its parent company, Mashup Media LLC. As a medical writer and editor, Mr. Dillard is experienced at producing high-quality clinical articles, blog articles, news releases, whitepapers, and a wide array of educational and promotional content pieces. Mr. Dillard has been writing in the health care space for over seven years and previously served as a public relations specialist, a field in which he holds a Bachelor of Arts degree from Rowan University. He lives in Manalapan, NJ, with his son.
Articles by Robert Dillard
Sacituzumab govitecan is associated with better QoL benefit than TPC in patients with HR+/HER2− BC.
Digital interventions that target physical and mental well-being are needed for adult long-term survivals of ALL.
Universal extracellular vesicles (EVs) and PD-L1-positive extracellular vesicles may be viable biomarkers for predicting ...
A study published in the British Journal of Cancer found that analyzing small extracellular vesicles (sEVs) could be useful ...
Researchers of a study developed an International Prognostic Index-based immune prognostic model (IPI-IPM) that yields robust ...
A study shows that label-free surface-enhanced Raman spectroscopy (SERS) in combination with descriptive analysis may ...
A study sought to explore the impact of intratumoral T-cell receptor (TCR) repertoire on interim positron emission tomography ...
Previous studies have shown that lymphomatous effusions in patients with diffuse large B-cell lymphoma (DLBCL) are linked ...
The results of a study indicate that artesunate (ART), a water-soluble derivative of artemisinin, may help in fighting ...
A study assessed clinical biological features in relapsed or refractory diffuse large B-cell lymphoma (DLBCL) patients to ...
A study which appeared in Annals of Palliative Medicine aimed to evaluate the prognostic significance of the advanced lung ...
A study assessed clinical characteristics and prognosis among patients with primary bone diffuse large B-cell lymphoma ...
A study shows that CREB binding protein (BP) inactivation may serve as robust therapeutic strategy in diffuse large B-cell ...
A study found that positron emission tomography with 18F-Fludeoxyglucose (FDG) integrated with computed tomography (18F-FDG ...
A study aimed to assess the clinicopathological characteristics of diffuse large B-cell lymphoma (DLBCL) among affected ...
Hematopoietic cell transplantation (HCT) may benefit therapy-sensitive patients with diffuse large B-cell lymphoma Richter ...
Patients with diffuse large B-cell lymphoma (DLBCL) and low socioeconomic status (SES) have worse survival outcomes, ...
A study found that the central nervous system international prognostic index (CNS-IPI), which is widely used for the ...
Short-term calorie reduction (SCR) may benefit patients with diffuse large B-cell lymphoma (DLBCL) according to a study ...
Some studies suggest that using 500 mg/m2 rituximab combined with a regimen of cyclophosphamide, doxorubicin, vincristine, ...
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.